Skip to Content
Merck
All Photos(1)

Documents

G-001

Supelco

GHB sodium salt solution

1.0 mg/mL in methanol (as salt), ampule of 1 mL, certified reference material, Cerilliant®

Synonym(s):

4-Hydroxybutyric acid sodium salt solution

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C4H7NaO3
CAS Number:
502-85-2
Molecular Weight:
126.09
EC Number:
200-659-6
MDL number:
MFCD00004402
UNSPSC Code:
41116107
NACRES:
NA.24

grade

certified reference material

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIA (Portugal)

concentration

1.0 mg/mL in methanol (as salt)

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

single component solution

storage temp.

−20°C

SMILES string

OCCCC([O-])=O.[Na+]

InChI

1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)/p-1

InChI key

SJZRECIVHVDYJC-UHFFFAOYSA-M

General description

GHB, or γ-hydroxybutyrate, is a central nervous system depressant sold under the brand name Xyrem® and used medically to treat narcolepsy, excessive daytime sleepiness and in rare circumstances, alcoholism. GHB is also used recreationally as an intoxicant and date rape drug. Its many street names include “GBH”, “Liquid X”, “G”, “Juice”, and “Mils”.

Application


  • GHB sodium salt in sleep disorder research: A study on nocturnal sodium oxybate, a form of GHB sodium salt, revealed an increase in the anterior cingulate cortex magnetic resonance glutamate signal upon awakening, suggesting its potential application in modulating brain function in sleep research (Dornbierer et al., 2023).

  • Investigation of GHB Na+ in alcohol-addiction treatment: Research focusing on the effect of the sodium salt of gamma-hydroxybutyrate (GHB) for alcohol-addiction treatment, it is effective in maintaining abstinence, with less craving for alcohol and lower rates of relapse (Frisoni et al., 2023).

  • Gamma-hydroxybutyrate sodium for in vitro biochemical assays: A detailed study on the pharmacokinetics and metabolism of gamma-hydroxybutyrate (GHB) in rats perturbed by alcohol, offers a model for in vitro studies examining GHB′s biochemical behavior and interaction with alcohol (Kim et al., 2023).

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Xyrem is a registered trademark of JPI Commercial, LLC

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Target Organs

Eyes

Storage Class Code

3 - Flammable liquids

WGK

WGK 1

Flash Point(F)

49.5 °F - closed cup

Flash Point(C)

9.7 °C - closed cup

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

R W Freudenmann et al.
Fortschritte der Neurologie-Psychiatrie, 81(2), 88-94 (2013-02-16)
In emergency medicine and anesthaesiology liquid ecstasy (LE), the street name for GHB, GBL or 1,4-B, has become infamous for causing severe intoxications and withdrawal. In general psychiatry, however, it is little known. Therefore, we set out to gather data
The limits of free speech.
Nature, 492(7429), 311-311 (2013-01-03)
When true enough is not good enough.
Nature medicine, 19(1), 1-1 (2013-01-09)
Jon Berner
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 9(1), 71-72 (2013-01-16)
Our case describes clinical features of two families defined by joint phenotypes: sodium oxybate intolerance and elevated serum acylcarnitines. Oxybate intolerance variably presents as either cervical dystonia or sleep-related eating disorder. Our objective is to identify biological markers which predict
Sodium oxybate: not authorised for fibromyalgia.
Prescrire international, 21(133), 290-290 (2013-02-02)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service